Skip to main content
Clinical Trials/NCT03436719
NCT03436719
Unknown
Not Applicable

Randomized Controlled Trial of Antibiotic Prophylaxis in Rectal Cancer Surgery: Oral With Intravenous Versus Intravenous Antibiotics.

State Scientific Centre of Coloproctology, Russian Federation1 site in 1 country280 target enrollmentNovember 6, 2017

Overview

Phase
Not Applicable
Intervention
Oral antibiotic
Conditions
Rectal Cancer
Sponsor
State Scientific Centre of Coloproctology, Russian Federation
Enrollment
280
Locations
1
Primary Endpoint
Rate of Surgical Site Infection
Last Updated
7 years ago

Overview

Brief Summary

This is a randomized, controlled, parallel study to determine the efficiency of oral antibiotics in reduction of surgical site infection (SSI) in rectal cancer surgery.

Detailed Description

Patients undergoing rectal cancer surgery in a single centre will assigned randomly to combined preoperative oral antibiotics (metronidazole and erythromycin) and perioperative intravenous antibiotics (cefmetazole) (oral+intravenous group) or to perioperative intravenous antibiotics (cefmetazole) alone (intravenous group). The primary endpoint is the overall rate of SSI.

Registry
clinicaltrials.gov
Start Date
November 6, 2017
End Date
August 31, 2020
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
State Scientific Centre of Coloproctology, Russian Federation
Responsible Party
Principal Investigator
Principal Investigator

Rybakov Evgeny, MD

Dr. Med. Sc. State Scientific Centre of Coloproctology, Head of Surgical department of oncoproctology, Moscow, Russian Federation

State Scientific Centre of Coloproctology, Russian Federation

Eligibility Criteria

Inclusion Criteria

  • Have a planned of resection of rectum
  • Have signed approved informed consent form for the study.

Exclusion Criteria

  • Significant simultaneous surgical procedure (e.g., liver resection of metastasis)
  • Bacterial infection at the time of surgery or antimicrobial therapy up to 4 weeks before surgery
  • Preoperative severe impairment in renal function (creatinine clearance (MDRD) \< 30 ml/min)
  • Allergy on the study drugs .

Arms & Interventions

Oral with Intravenous

Oral metronidazole and erythromycine administration on the day before surgery with intravenous cefoperazone before surgery (30-90 min) and additional doses every third hour during surgery

Intervention: Oral antibiotic

Oral with Intravenous

Oral metronidazole and erythromycine administration on the day before surgery with intravenous cefoperazone before surgery (30-90 min) and additional doses every third hour during surgery

Intervention: Intravenous antibiotic

Oral with Intravenous

Oral metronidazole and erythromycine administration on the day before surgery with intravenous cefoperazone before surgery (30-90 min) and additional doses every third hour during surgery

Intervention: Mechanical Bowel Preparation

Intravenous

Intravenous dose cefoperazone before surgery (30-90 min) and additional doses every third hour during surgery

Intervention: Intravenous antibiotic

Intravenous

Intravenous dose cefoperazone before surgery (30-90 min) and additional doses every third hour during surgery

Intervention: Mechanical Bowel Preparation

Outcomes

Primary Outcomes

Rate of Surgical Site Infection

Time Frame: 0 to 30 days

Study Sites (1)

Loading locations...

Similar Trials